Ilika to scale up, commercialize next-gen fuel cell catalysts

• Publisher: Elsevier Science
• Year: 2011
• Weight: 52 KB
• Volume: 2011
• Category: Article
• ISSN: 1351-4180
• DOI: 10.1016/s1351-4180(11)70075-7

✦ Synopsis

Codexis Inc announce signing of an enzyme supply agreement. The agreement grants DSM rights to use Codexis' custom biocatalysts and services, and secures supply of Codexis enzymes for commercialising sustainable enzyme-based pharmaceutical manufacturing routes developed by DSM's InnoSyn route scouting services. Codexis technology enables development of new efficient manufacturing processes for active pharmaceutical ingredients and intermediates which reduce cost and environmental waste.